These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32523087)

  • 1. Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome.
    Werner L; Dreyer JH; Hartmann D; Barros MHM; Büttner-Herold M; Grittner U; Niedobitek G
    Sci Rep; 2020 Jun; 10(1):9410. PubMed ID: 32523087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
    Abd Allah MYY; Fahmi MW; El-Ashwah S
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
    Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
    Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.
    Arlt A; von Bonin F; Rehberg T; Perez-Rubio P; Engelmann JC; Limm K; Reinke S; Dullin C; Sun X; Specht R; Maulhardt M; Linke F; Bunt G; Klapper W; Vockerodt M; Wilting J; Pukrop T; Dettmer K; Gronwald W; Oefner PJ; Spang R; Kube D
    Mol Oncol; 2020 Mar; 14(3):571-589. PubMed ID: 31825135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
    Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
    Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
    Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
    Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
    Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
    Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
    Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
    Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.
    Antel K; Chetty D; Oosthuizen J; Mohamed Z; Van der Vyver L; Verburgh E
    Pathology; 2021 Aug; 53(5):628-634. PubMed ID: 33558066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
    Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
    Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
    Barros MH; Hassan R; Niedobitek G
    Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
    Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
    Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.
    Panico L; Ronconi F; Lepore M; Tenneriello V; Cantore N; Dell'Angelo AC; Ferbo U; Ferrara F
    Leuk Lymphoma; 2013 Nov; 54(11):2418-25. PubMed ID: 23432688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
    Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
    Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
    Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
    Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Shimizu-Kohno K; Kato S; Tomita A; Kinoshita T; Nakamura S; Asano N
    Pathol Int; 2015 Dec; 65(12):652-60. PubMed ID: 26538151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.
    Kayal S; Mathur S; Karak AK; Kumar L; Sharma A; Bakhshi S; Raina V
    Leuk Lymphoma; 2014 May; 55(5):1031-7. PubMed ID: 24067108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
    Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.